Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma

Autor: Borbath, I., Verbrugghe, L., Lai, R., Gigot, J.F., Humblet, Y., Piessevaux, H., Sempoux, C.
Zdroj: In European Journal of Cancer May 2012 48(7):990-996
Databáze: ScienceDirect
Externí odkaz: